We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
-3.79%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$7.76B
AUM Growth
+$2.97B
Cap. Flow
+$3.25B
Cap. Flow %
41.9%
Top 10 Hldgs %
89.2%
Holding
459
New
273
Increased
39
Reduced
24
Closed
76

Sector Composition

Rank Sector Weight
1 Healthcare 0.6%
2 Technology 0.48%
3 Financials 0.42%
4 Consumer Discretionary 0.34%
5 Industrials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLO
351
DELISTED
Olo Inc
OLO
$69.4K ﹤0.01%
+11,446
New +$74.8K
PTON icon
352
Peloton Interactive
PTON
$2.39B
$63.9K ﹤0.01%
+12,647
New +$90K
SPCE icon
353
Virgin Galactic
SPCE
$398M
$60.2K ﹤0.01%
+1,673
New +$99.7K
ALLO icon
354
Allogene Therapeutics
ALLO
$704M
$58.3K ﹤0.01%
+18,377
New +$80.5K
VISN
355
Vistance Networks Inc
VISN
$2.59B
$57.3K ﹤0.01%
+17,056
New +$69.8K
TLRY icon
356
Tilray
TLRY
$601M
$54.7K ﹤0.01%
+2,287
New +$54K
EGY icon
357
Vaalco Energy
EGY
$605M
$53.4K ﹤0.01%
+12,165
New +$52.9K
OPTU
358
Optimum Communications Inc
OPTU
$287M
$47.6K ﹤0.01%
+14,565
New +$47K
RYAM icon
359
Rayonier Advanced Materials
RYAM
$598M
$47.2K ﹤0.01%
+13,338
New +$50.1K
EBS icon
360
Emergent Biosolutions
EBS
$231M
$46.9K ﹤0.01%
+13,781
New +$76.4K
FUBO icon
361
FuboTV Inc
FUBO
$265M
$44.6K ﹤0.01%
+1,391
New +$43.1K
CHRS icon
362
Coherus Oncology
CHRS
$201M
$42.8K ﹤0.01%
+11,452
New +$52.9K
TDAY
363
USA Today Co
TDAY
$1.05B
$39.1K ﹤0.01%
+15,975
New +$44.2K
VMEO
364
DELISTED
Vimeo
VMEO
$37K ﹤0.01%
+10,457
New +$41.4K
FATE icon
365
Fate Therapeutics
FATE
$323M
$36.8K ﹤0.01%
+17,337
New +$57.4K
MVST icon
366
Microvast
MVST
$285M
$35K ﹤0.01%
+18,508
New +$39.6K
OPK icon
367
Opko Health
OPK
$1.02B
$32.2K ﹤0.01%
+20,153
New +$36.7K
CLOV icon
368
Clover Health Investments
CLOV
$2.44B
$31K ﹤0.01%
+28,693
New +$34.1K
KPTI icon
369
Karyopharm Therapeutics
KPTI
$46M
$30.6K ﹤0.01%
+1,522
New +$34.2K
EGHT icon
370
8x8 Inc
EGHT
$328M
$28.9K ﹤0.01%
+11,458
New +$40.7K
TELL
371
DELISTED
Tellurian Inc.
TELL
$28.3K ﹤0.01%
+24,407
New +$33.2K
REI icon
372
Ring Energy
REI
$349M
$20.7K ﹤0.01%
+10,596
New +$21.2K
GEVO icon
373
Gevo
GEVO
$380M
$20.6K ﹤0.01%
+17,273
New +$25.5K
AGEN
374
Agenus
AGEN
$285M
$18.2K ﹤0.01%
+807
New +$22.9K
CTEV
375
Claritev Corp
CTEV
$591M
$17.1K ﹤0.01%
+254
New +$18.8K

Similar funds

Brevan Howard Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Brevan Howard Capital Management held 459 positions worth $7.76B, up 62% from $4.79B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Brevan Howard Capital Management deployed $3.25B of net new capital in Q3 2023, opening 273 new positions and adding to 39 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 374,801 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 0.6% of assets, down from 0.83% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $53.7M trimmed.

  • Brevan Howard Capital Management's largest Q3 2023 buy was State Street Financial Select Sector SPDR ETF: 374,801 shares worth $12.4M.
  • Brevan Howard Capital Management added most to Spirit AeroSystems in Q3 2023, an estimated $1.92M increase.
  • Brevan Howard Capital Management's biggest Q3 2023 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $53.7M.
  • Brevan Howard Capital Management fully exited iShares 20+ Year Treasury Bond ETF in Q3 2023, selling an estimated $81M.
  • Brevan Howard Capital Management's ten largest holdings make up 89% of its $7.76B portfolio in Q3 2023.
  • Brevan Howard Capital Management opened 273 new positions and closed 76 in Q3 2023.
  • Brevan Howard Capital Management's portfolio value rose 62% quarter-over-quarter to $7.76B.

Based on Brevan Howard Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.